Counteracting the Effects of Anticoagulants and Antiplatelet Agents during Neurosurgical Emergencies

This publication has 42 references indexed in Scilit:

• Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
  Chest, 2004
• Massive transfusion and coagulopathy: pathophysiology and implications for clinical management
  Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2004
• The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
  Neurocritical Care, 2004
• Guidelines for the use of platelet transfusions
  British Journal of Haematology, 2003
• The interaction between platelets and factor VII/VIIa
  Transfusion and Apheresis Science, 2003
• The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings
  Journal of Neurosurgery, 2003
• Desmopressin in Mild Hemophilia A: Indications, Limitations, Efficacy, and Safety
  Seminars in Thrombosis and Hemostasis, 2003
• Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects
  Intensive Care Medicine, 2001
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (αIIb/β3) receptor-directed platelet inhibition
  American Heart Journal, 2001
• Hextend[registered sign], a Physiologically Balanced Plasma Expander for Large Volume Use in Major Surgery
  Anesthesia & Analgesia, 1999